Videos de Experimentos Relacionados
Estrategia de prueba de la tiroides estrategia de prueba de la tiroides.
Lancet (London, England)
|August 31, 1985
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Neoadjuvant radiochemotherapy in patients with high-risk locally advanced cervical cancer-results of a clinical series.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2025
Same author
[Not Available].
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2016
Same author
Fractionated external beam radiotherapy of skull base metastases with cranial nerve involvement.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2013
Same author
Second primary malignancies in head and neck cancer patients: high prevalence of curable-stage disease.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2013
Same author
Increasing toxicity during neoadjuvant radiochemotherapy as positive prognostic factor for patients with esophageal carcinoma.
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2013
Same author
Testicular radiation dose after multimodal curative therapy for locally advanced rectal cancer. Influence on hormone levels, quality of life, and sexual functioning.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2012
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026